Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases

Public statements about the effect of smoking on cardiovascular disease are predominantly based on investigations of coronary heart disease (CHD) and stroke, although smoking is recognized as a strong risk factor for peripheral artery disease (PAD). No study has comprehensively compared the long-ter...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 74; no. 4; p. 498
Main Authors: Ding, Ning, Sang, Yingying, Chen, Jingsha, Ballew, Shoshana H, Kalbaugh, Corey A, Salameh, Maya J, Blaha, Michael J, Allison, Matthew, Heiss, Gerardo, Selvin, Elizabeth, Coresh, Josef, Matsushita, Kunihiro
Format: Journal Article
Language:English
Published: United States 30.07.2019
Subjects:
ISSN:1558-3597, 1558-3597
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Public statements about the effect of smoking on cardiovascular disease are predominantly based on investigations of coronary heart disease (CHD) and stroke, although smoking is recognized as a strong risk factor for peripheral artery disease (PAD). No study has comprehensively compared the long-term association of cigarette smoking and its cessation with the incidence of 3 major atherosclerotic diseases (PAD, CHD, and stroke). The aim of this study was to quantify the long-term association of cigarette smoking and its cessation with the incidence of the 3 outcomes. A total of 13,355 participants aged 45 to 64 years in the ARIC (Atherosclerosis Risk In Communities) study without PAD, CHD, or stroke at baseline (1987 to 1989) were included. The associations of smoking parameters (pack-years, duration, intensity, and cessation) with incident PAD were quantified and contrasted with CHD and stroke using Cox models. Over a median follow-up of 26 years, there were 492 PAD cases, 1,798 CHD cases, and 1,106 stroke cases. A dose-response relationship was identified between pack-years of smoking and 3 outcomes, with the strongest results for PAD. The pattern was consistent when investigating duration and intensity separately. A longer period of smoking cessation was consistently related to lower risk of PAD, CHD, and stroke, but a significantly elevated risk persisted up to 30 years following smoking cessation for PAD and up to 20 years for CHD. All smoking measures showed significant associations with 3 major atherosclerotic diseases, with the strongest effect size for incident PAD. The risk due to smoking lasted up to 30 years for PAD and 20 years for CHD. Our results further highlight the importance of smoking prevention and early smoking cessation, and indicate the need for public statements to take PAD into account when acknowledging the impact of smoking on overall cardiovascular health.
AbstractList Public statements about the effect of smoking on cardiovascular disease are predominantly based on investigations of coronary heart disease (CHD) and stroke, although smoking is recognized as a strong risk factor for peripheral artery disease (PAD). No study has comprehensively compared the long-term association of cigarette smoking and its cessation with the incidence of 3 major atherosclerotic diseases (PAD, CHD, and stroke).BACKGROUNDPublic statements about the effect of smoking on cardiovascular disease are predominantly based on investigations of coronary heart disease (CHD) and stroke, although smoking is recognized as a strong risk factor for peripheral artery disease (PAD). No study has comprehensively compared the long-term association of cigarette smoking and its cessation with the incidence of 3 major atherosclerotic diseases (PAD, CHD, and stroke).The aim of this study was to quantify the long-term association of cigarette smoking and its cessation with the incidence of the 3 outcomes.OBJECTIVESThe aim of this study was to quantify the long-term association of cigarette smoking and its cessation with the incidence of the 3 outcomes.A total of 13,355 participants aged 45 to 64 years in the ARIC (Atherosclerosis Risk In Communities) study without PAD, CHD, or stroke at baseline (1987 to 1989) were included. The associations of smoking parameters (pack-years, duration, intensity, and cessation) with incident PAD were quantified and contrasted with CHD and stroke using Cox models.METHODSA total of 13,355 participants aged 45 to 64 years in the ARIC (Atherosclerosis Risk In Communities) study without PAD, CHD, or stroke at baseline (1987 to 1989) were included. The associations of smoking parameters (pack-years, duration, intensity, and cessation) with incident PAD were quantified and contrasted with CHD and stroke using Cox models.Over a median follow-up of 26 years, there were 492 PAD cases, 1,798 CHD cases, and 1,106 stroke cases. A dose-response relationship was identified between pack-years of smoking and 3 outcomes, with the strongest results for PAD. The pattern was consistent when investigating duration and intensity separately. A longer period of smoking cessation was consistently related to lower risk of PAD, CHD, and stroke, but a significantly elevated risk persisted up to 30 years following smoking cessation for PAD and up to 20 years for CHD.RESULTSOver a median follow-up of 26 years, there were 492 PAD cases, 1,798 CHD cases, and 1,106 stroke cases. A dose-response relationship was identified between pack-years of smoking and 3 outcomes, with the strongest results for PAD. The pattern was consistent when investigating duration and intensity separately. A longer period of smoking cessation was consistently related to lower risk of PAD, CHD, and stroke, but a significantly elevated risk persisted up to 30 years following smoking cessation for PAD and up to 20 years for CHD.All smoking measures showed significant associations with 3 major atherosclerotic diseases, with the strongest effect size for incident PAD. The risk due to smoking lasted up to 30 years for PAD and 20 years for CHD. Our results further highlight the importance of smoking prevention and early smoking cessation, and indicate the need for public statements to take PAD into account when acknowledging the impact of smoking on overall cardiovascular health.CONCLUSIONSAll smoking measures showed significant associations with 3 major atherosclerotic diseases, with the strongest effect size for incident PAD. The risk due to smoking lasted up to 30 years for PAD and 20 years for CHD. Our results further highlight the importance of smoking prevention and early smoking cessation, and indicate the need for public statements to take PAD into account when acknowledging the impact of smoking on overall cardiovascular health.
Public statements about the effect of smoking on cardiovascular disease are predominantly based on investigations of coronary heart disease (CHD) and stroke, although smoking is recognized as a strong risk factor for peripheral artery disease (PAD). No study has comprehensively compared the long-term association of cigarette smoking and its cessation with the incidence of 3 major atherosclerotic diseases (PAD, CHD, and stroke). The aim of this study was to quantify the long-term association of cigarette smoking and its cessation with the incidence of the 3 outcomes. A total of 13,355 participants aged 45 to 64 years in the ARIC (Atherosclerosis Risk In Communities) study without PAD, CHD, or stroke at baseline (1987 to 1989) were included. The associations of smoking parameters (pack-years, duration, intensity, and cessation) with incident PAD were quantified and contrasted with CHD and stroke using Cox models. Over a median follow-up of 26 years, there were 492 PAD cases, 1,798 CHD cases, and 1,106 stroke cases. A dose-response relationship was identified between pack-years of smoking and 3 outcomes, with the strongest results for PAD. The pattern was consistent when investigating duration and intensity separately. A longer period of smoking cessation was consistently related to lower risk of PAD, CHD, and stroke, but a significantly elevated risk persisted up to 30 years following smoking cessation for PAD and up to 20 years for CHD. All smoking measures showed significant associations with 3 major atherosclerotic diseases, with the strongest effect size for incident PAD. The risk due to smoking lasted up to 30 years for PAD and 20 years for CHD. Our results further highlight the importance of smoking prevention and early smoking cessation, and indicate the need for public statements to take PAD into account when acknowledging the impact of smoking on overall cardiovascular health.
Author Chen, Jingsha
Ding, Ning
Selvin, Elizabeth
Sang, Yingying
Blaha, Michael J
Coresh, Josef
Heiss, Gerardo
Ballew, Shoshana H
Kalbaugh, Corey A
Allison, Matthew
Matsushita, Kunihiro
Salameh, Maya J
Author_xml – sequence: 1
  givenname: Ning
  surname: Ding
  fullname: Ding, Ning
  organization: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
– sequence: 2
  givenname: Yingying
  surname: Sang
  fullname: Sang, Yingying
  organization: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
– sequence: 3
  givenname: Jingsha
  surname: Chen
  fullname: Chen, Jingsha
  organization: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
– sequence: 4
  givenname: Shoshana H
  surname: Ballew
  fullname: Ballew, Shoshana H
  organization: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
– sequence: 5
  givenname: Corey A
  surname: Kalbaugh
  fullname: Kalbaugh, Corey A
  organization: University of North Carolina at Chapel Hill Department of Surgery, Chapel Hill, North Carolina
– sequence: 6
  givenname: Maya J
  surname: Salameh
  fullname: Salameh, Maya J
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland
– sequence: 7
  givenname: Michael J
  surname: Blaha
  fullname: Blaha, Michael J
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland
– sequence: 8
  givenname: Matthew
  surname: Allison
  fullname: Allison, Matthew
  organization: University of California San Diego School of Medicine, La Jolla, California
– sequence: 9
  givenname: Gerardo
  surname: Heiss
  fullname: Heiss, Gerardo
  organization: University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, North Carolina
– sequence: 10
  givenname: Elizabeth
  surname: Selvin
  fullname: Selvin, Elizabeth
  organization: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Johns Hopkins University School of Medicine, Baltimore, Maryland
– sequence: 11
  givenname: Josef
  surname: Coresh
  fullname: Coresh, Josef
  organization: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Johns Hopkins University School of Medicine, Baltimore, Maryland
– sequence: 12
  givenname: Kunihiro
  surname: Matsushita
  fullname: Matsushita, Kunihiro
  email: kuni.matsushita@jhu.edu
  organization: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: kuni.matsushita@jhu.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31345423$$D View this record in MEDLINE/PubMed
BookMark eNpNkLtOwzAYhS1URC_wAgzII0MTbCd27LFKuUlFSFBWIif5XZwmcYnTgbfps_TJqEQrsZzzDZ_OcMZo0LoWELqmJKSEirsqrHRRhIxQFRIeklidoRHlXAYRV8ngHw_R2PuKECIkVRdoGNEo5jGLRugztSvdQd8Dfm_c2rar6QlwCt7r3rp2inVb4oVrV8ESuga_Wb_GzuBov3vRlev2u1n_BZ3zRX3I3hZ4bj1oD_4SnRtde7g69gR9PNwv06dg8fr4nM4WQcGl6gNFQfGEGqIhJ0bkjGgjTEmFEIkyBY81JGA0ExCXkgvOmRQqSrgwuYlAGjZBt3-7m859b8H3WWN9AXWtW3BbnzEmeCJIQuVBvTmq27yBMtt0ttHdT3b6hP0CvJxnww
CitedBy_id crossref_primary_10_3390_diagnostics13193145
crossref_primary_10_1016_j_jacc_2019_06_003
crossref_primary_10_1055_a_2273_1722
crossref_primary_10_1177_17085381221076673
crossref_primary_10_3390_ijms242417439
crossref_primary_10_1002_advs_202501820
crossref_primary_10_1016_j_ypmed_2024_108085
crossref_primary_10_3390_biology10050441
crossref_primary_10_1111_prd_12561
crossref_primary_10_18087_cardio_2024_12_n2686
crossref_primary_10_1016_j_iccl_2024_11_012
crossref_primary_10_15829_1560_4071_2021_4278
crossref_primary_10_1001_jamanetworkopen_2022_40188
crossref_primary_10_1016_j_cjca_2019_10_021
crossref_primary_10_1016_j_jacc_2023_04_003
crossref_primary_10_1093_ntr_ntaf165
crossref_primary_10_1186_s12964_024_01480_6
crossref_primary_10_3390_jcm10112450
crossref_primary_10_1093_ntr_ntae199
crossref_primary_10_1161_CIRCRESAHA_121_318535
crossref_primary_10_26599_1671_5411_2025_01_008
crossref_primary_10_1002_advs_202304748
crossref_primary_10_1016_j_envres_2022_113730
crossref_primary_10_1136_svn_2020_000493
crossref_primary_10_13105_wjma_v11_i6_290
crossref_primary_10_54022_shsv6n2_033
crossref_primary_10_1007_s11298_019_7396_z
crossref_primary_10_1016_j_heliyon_2024_e24189
crossref_primary_10_1136_heartjnl_2021_318972
crossref_primary_10_1186_s12889_024_19457_y
crossref_primary_10_2337_dc23_1503
crossref_primary_10_3389_fpubh_2025_1643059
crossref_primary_10_3390_diagnostics13020274
crossref_primary_10_1161_JAHA_121_021976
crossref_primary_10_14814_phy2_14369
crossref_primary_10_3390_biomedicines11123157
crossref_primary_10_1093_eurheartj_ehad616
crossref_primary_10_1093_eurheartj_ehae705
crossref_primary_10_1055_a_1221_6985
crossref_primary_10_3390_ijerph19116564
crossref_primary_10_1093_eurheartj_ehaa460
crossref_primary_10_1161_CIRCRESAHA_121_320702
crossref_primary_10_3390_healthcare13050529
crossref_primary_10_1016_j_heliyon_2020_e05450
crossref_primary_10_1097_CPT_0000000000000280
crossref_primary_10_3390_diagnostics12061500
crossref_primary_10_1038_s41398_024_03063_y
crossref_primary_10_1177_0976500X241246412
crossref_primary_10_1515_jom_2024_0050
crossref_primary_10_1016_j_jacc_2024_02_013
crossref_primary_10_1016_j_clnesp_2024_04_001
crossref_primary_10_1093_eurheartj_ehab541
crossref_primary_10_1055_s_0043_57257
crossref_primary_10_1016_j_jacc_2022_03_377
crossref_primary_10_1097_JCN_0000000000001224
crossref_primary_10_1016_j_cpcardiol_2021_101082
crossref_primary_10_1155_2022_9943158
crossref_primary_10_1007_s11239_023_02812_y
crossref_primary_10_1186_s12872_023_03079_0
crossref_primary_10_1097_FJC_0000000000001556
crossref_primary_10_3390_jcdd10040164
crossref_primary_10_1371_journal_pone_0321491
crossref_primary_10_1016_j_jvsvi_2024_100174
crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_106203
crossref_primary_10_1001_jama_2021_2126
crossref_primary_10_1053_j_semvascsurg_2024_09_001
crossref_primary_10_3390_jcm12113652
crossref_primary_10_1080_0886022X_2025_2453014
crossref_primary_10_3390_ijms23021002
crossref_primary_10_1016_j_acra_2019_08_017
crossref_primary_10_1186_s12877_025_06228_6
crossref_primary_10_4103_lungindia_lungindia_518_24
crossref_primary_10_1093_eurheartj_ehac016
crossref_primary_10_1177_15443167241257626
crossref_primary_10_1186_s40779_023_00463_x
crossref_primary_10_1007_s11883_020_00871_7
crossref_primary_10_1161_CIR_0000000000001168
crossref_primary_10_18332_tid_175632
crossref_primary_10_1007_s11886_024_02063_0
crossref_primary_10_1161_CIR_0000000000001052
crossref_primary_10_1590_0100_6991e_20233482_en
crossref_primary_10_1016_j_pcad_2025_07_007
crossref_primary_10_1001_jamanetworkopen_2020_34461
crossref_primary_10_3390_ijms241813920
crossref_primary_10_1161_STROKEAHA_124_046956
crossref_primary_10_3390_life15081226
crossref_primary_10_23736_S0392_9590_20_04288_1
crossref_primary_10_1016_j_numecd_2021_05_025
crossref_primary_10_1161_CIR_0000000000000967
crossref_primary_10_3389_fcvm_2022_923549
crossref_primary_10_1007_s00772_023_01039_8
crossref_primary_10_1161_CIRCULATIONAHA_121_053797
crossref_primary_10_1053_j_ajkd_2023_10_008
crossref_primary_10_1097_MD_0000000000039996
crossref_primary_10_1016_j_ijcrp_2025_200469
crossref_primary_10_1016_j_mayocp_2023_05_008
crossref_primary_10_1016_j_ijcard_2020_05_016
crossref_primary_10_1111_jch_14905
crossref_primary_10_4178_epih_e2024064
crossref_primary_10_1093_eurjpc_zwaf222
crossref_primary_10_1016_j_atherosclerosis_2021_03_019
crossref_primary_10_1097_HCR_0000000000000518
crossref_primary_10_1002_clc_24214
crossref_primary_10_1016_j_amjcard_2024_03_002
crossref_primary_10_1016_j_jvs_2025_01_007
crossref_primary_10_1177_1358863X221143152
crossref_primary_10_1016_j_heliyon_2024_e37869
crossref_primary_10_1016_j_hlc_2025_07_005
crossref_primary_10_1016_j_diabres_2023_110869
crossref_primary_10_1002_smi_3106
crossref_primary_10_1093_eurjpc_zwae040
crossref_primary_10_1007_s00772_024_01086_9
crossref_primary_10_3389_ftox_2024_1395670
crossref_primary_10_1186_s12872_021_02302_0
crossref_primary_10_1007_s00772_025_01190_4
crossref_primary_10_1177_07334648241230010
crossref_primary_10_3390_healthcare12242553
crossref_primary_10_1002_clc_24003
crossref_primary_10_18332_tid_162380
crossref_primary_10_1016_j_heliyon_2024_e34602
crossref_primary_10_1142_S0192415X24500381
crossref_primary_10_1177_1358863X251330583
crossref_primary_10_1016_j_amepre_2023_01_001
crossref_primary_10_1186_s12889_025_22865_3
crossref_primary_10_1136_bmjgh_2024_017049
crossref_primary_10_1161_CIR_0000000000001005
crossref_primary_10_1590_0100_6991e_20233482
crossref_primary_10_1161_ATVBAHA_120_315828
crossref_primary_10_1161_CIR_0000000000001123
crossref_primary_10_1016_j_jacl_2024_12_007
crossref_primary_10_1161_CIR_0000000000001251
crossref_primary_10_1055_a_2360_7551
crossref_primary_10_3390_jcm12206516
crossref_primary_10_1016_j_amjcard_2024_11_008
crossref_primary_10_1016_j_amjcard_2021_02_012
crossref_primary_10_1161_ATVBAHA_120_314824
crossref_primary_10_1016_j_msard_2022_103501
crossref_primary_10_1186_s12889_024_18468_z
crossref_primary_10_23946_2500_0764_2024_9_1_42_52
crossref_primary_10_1016_j_envres_2023_118056
crossref_primary_10_1002_cncr_34132
crossref_primary_10_1111_dom_15583
crossref_primary_10_2215_CJN_15751020
crossref_primary_10_1016_j_ajpc_2025_101080
crossref_primary_10_1093_eurheartj_ehad685
crossref_primary_10_1161_CIR_0000000000001105
crossref_primary_10_3389_fendo_2021_750773
crossref_primary_10_1053_j_semvascsurg_2022_04_003
crossref_primary_10_1038_s44325_024_00006_w
crossref_primary_10_23736_S0392_9590_25_05344_1
crossref_primary_10_1016_j_biopha_2021_112493
crossref_primary_10_1111_jdi_14048
crossref_primary_10_1093_ntr_ntab076
crossref_primary_10_1002_ana_26647
crossref_primary_10_1016_j_amepre_2024_10_008
crossref_primary_10_1007_s11936_024_01070_2
crossref_primary_10_1038_s41598_025_88516_0
crossref_primary_10_1016_j_jvn_2025_01_003
crossref_primary_10_1007_s12181_023_00659_4
crossref_primary_10_1136_bmjsem_2021_001048
crossref_primary_10_1186_s12931_024_02760_y
crossref_primary_10_1111_psyp_14081
crossref_primary_10_1016_j_jvs_2025_03_002
crossref_primary_10_1080_10408444_2020_1740972
crossref_primary_10_1111_jcpp_14180
crossref_primary_10_1097_01_HJ_0000874576_86751_53
crossref_primary_10_1016_j_jacc_2023_09_830
crossref_primary_10_1136_bmjdrc_2023_003523
crossref_primary_10_3390_medicina60111781
crossref_primary_10_1016_j_mcna_2023_05_007
crossref_primary_10_1161_CIR_0000000000001209
crossref_primary_10_1007_s00423_021_02381_9
crossref_primary_10_1371_journal_pone_0320573
crossref_primary_10_1007_s00772_022_00963_5
crossref_primary_10_1016_j_jscai_2025_103609
crossref_primary_10_1038_s41393_020_00566_5
crossref_primary_10_1016_j_jacasi_2022_10_013
crossref_primary_10_1016_j_atherosclerosis_2022_02_017
crossref_primary_10_1016_j_jos_2024_06_012
crossref_primary_10_1016_j_diabres_2024_111771
crossref_primary_10_3390_molecules26040811
crossref_primary_10_1177_00033197241312940
crossref_primary_10_1016_j_jacadv_2024_100993
crossref_primary_10_1177_17539447221096940
crossref_primary_10_1016_j_jacadv_2024_100994
crossref_primary_10_1017_S0954579424001561
crossref_primary_10_1007_s00772_020_00627_2
crossref_primary_10_1007_s00772_021_00855_0
crossref_primary_10_3389_fendo_2024_1493663
crossref_primary_10_1161_CIR_0000000000001303
crossref_primary_10_1177_2047487320918728
crossref_primary_10_1016_j_annepidem_2020_03_010
crossref_primary_10_1161_JAHA_120_017320
crossref_primary_10_1097_JS9_0000000000001922
crossref_primary_10_1161_ATVBAHA_119_312142
crossref_primary_10_1016_j_ijcard_2022_12_008
crossref_primary_10_18332_tid_118719
ContentType Journal Article
Copyright Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jacc.2019.05.049
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
ExternalDocumentID 31345423
Genre Journal Article
Comparative Study
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HHSN268201700004I
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700005I
– fundername: NHLBI NIH HHS
  grantid: R21 HL133694
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700001C
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700002I
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700003I
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700001I
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700004C
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700005C
– fundername: NHLBI NIH HHS
  grantid: HHSN268201700003C
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
1~5
2WC
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
AABNK
AABVL
AAEDT
AAEDW
AAIKJ
AAKUH
AALRI
AAOAW
AAQFI
AAQQT
AAXUO
ABBQC
ABFNM
ABFRF
ABLJU
ABMAC
ABMZM
ABOCM
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFCTW
AFETI
AFPUW
AFRAH
AFRHN
AFTJW
AGCQF
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BLXMC
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EFKBS
EIF
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FNPLU
G-Q
GBLVA
GX1
HVGLF
IHE
IXB
J1W
K-O
KQ8
L7B
MO0
N9A
NPM
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SSZ
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
YYM
YZZ
Z5R
7X8
EFLBG
~HD
ID FETCH-LOGICAL-c589t-91e9571f0aeb0f6b20af6fd166679fc54ae7efa26e4d8565528693756fbf3e8f2
IEDL.DBID 7X8
ISICitedReferencesCount 199
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000476594000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1558-3597
IngestDate Thu Oct 02 10:39:54 EDT 2025
Mon Jul 21 06:03:01 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords cigarette smoking
coronary heart disease
peripheral artery disease
smoking cessation
stroke
Language English
License Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c589t-91e9571f0aeb0f6b20af6fd166679fc54ae7efa26e4d8565528693756fbf3e8f2
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S073510971935449X
PMID 31345423
PQID 2265760718
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2265760718
pubmed_primary_31345423
PublicationCentury 2000
PublicationDate 2019-07-30
PublicationDateYYYYMMDD 2019-07-30
PublicationDate_xml – month: 07
  year: 2019
  text: 2019-07-30
  day: 30
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2019
References 31345424 - J Am Coll Cardiol. 2019 Jul 30;74(4):508-511. doi: 10.1016/j.jacc.2019.06.003.
References_xml – reference: 31345424 - J Am Coll Cardiol. 2019 Jul 30;74(4):508-511. doi: 10.1016/j.jacc.2019.06.003.
SSID ssj0006819
Score 2.6578016
Snippet Public statements about the effect of smoking on cardiovascular disease are predominantly based on investigations of coronary heart disease (CHD) and stroke,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 498
SubjectTerms Atherosclerosis - epidemiology
Atherosclerosis - etiology
Cigarette Smoking - adverse effects
Coronary Disease - epidemiology
Coronary Disease - etiology
Female
Humans
Incidence
Male
Middle Aged
Peripheral Arterial Disease - epidemiology
Peripheral Arterial Disease - etiology
Prospective Studies
Risk Assessment
Risk Factors
Smoking Cessation
Stroke - epidemiology
Stroke - etiology
Time Factors
Title Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases
URI https://www.ncbi.nlm.nih.gov/pubmed/31345423
https://www.proquest.com/docview/2265760718
Volume 74
WOSCitedRecordID wos000476594000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvDYxTz3cZJSLR7aUrRCD0LYbHalFbO1qf5-Z5OU3kTwEkIg2TAzmfkyMzsfQjepilMZcU2YnwoShTQjnIqURFkQUuVTwXTJWtJjgwEfj8WwTrgVdVvl0ieWjjqzyuXIbwEmADSGgMjvZp_EsUa56mpNobGOGiFAGdfSxcaraeGUl8QeEDI5CQE515tmqv6uqVRuhKEvysmd0S8Qsww13d3_vuQe2qlBJm5XVrGP1nR-gLb6dRn9EL12JiW77ULj5w_rkuWt5QnuOE4Up60WlnmGezZ_IyNw3_hpUrxja3CI-3Jq57jtoKMtYIG5hXXwfVXqKY7QS_dh1HkkNc0CUTEXC3B3WsTMN57UqWdoGnjSUJO5eiITRsWR1EwbGVAdZRzwXxyANkMWU5OaUHMTHKON3Ob6FGEF17QOMvhLMhAdg1T4Ap4UiEywWFDVRNdLuSVgxq42IXNtv4pkJbkmOqmEn8yqeRsJqDaKAfad_eHuc7TtdFpmX70L1DDwEetLtKm-F5NiflXaBxwHw_4PAobEVg
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cigarette+Smoking%2C+Smoking+Cessation%2C+and+Long-Term+Risk+of+3+Major+Atherosclerotic+Diseases&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Ding%2C+Ning&rft.au=Sang%2C+Yingying&rft.au=Chen%2C+Jingsha&rft.au=Ballew%2C+Shoshana+H&rft.date=2019-07-30&rft.issn=1558-3597&rft.eissn=1558-3597&rft.volume=74&rft.issue=4&rft.spage=498&rft_id=info:doi/10.1016%2Fj.jacc.2019.05.049&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-3597&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-3597&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-3597&client=summon